Development of a Traveler’s Vaccine against Dengue Infection

Authors

Arthur Lee, Brigham Young University
Dr. Bradford Berges, Brigham Young University

Keywords

traveler's vaccine, dengue infection, hemorrhagic fever, shock syndrome

College

Life Sciences

Department

Microbiology and Molecular Biology

Abstract

There are currently no vaccines available against dengue virus. Each year, about 400 million people become infected and half a million of them, especially children, develop complications such as dengue hemorrhagic fever or dengue shock syndrome.

Recommended Citation

Lee, Arthur and Berges, Dr. Bradford (2014) "Development of a Traveler’s Vaccine against Dengue Infection," Journal of Undergraduate Research: Vol. 2014: Iss. 1, Article 777.
Available at: https://scholarsarchive.byu.edu/jur/vol2014/iss1/777